These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18628607)

  • 21. KDR-5169, a new gastrointestinal prokinetic agent, enhances gastric contractile and emptying activities in dogs and rats.
    Tazawa S; Masuda N; Koizumi T; Kitazawa M; Nakane T; Miyata H
    Eur J Pharmacol; 2002 Jan; 434(3):169-76. PubMed ID: 11779580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of prokinetic agents in improving bowel preparation for colonoscopy.
    Mishima Y; Amano Y; Okita K; Takahashi Y; Moriyama N; Ishimura N; Furuta K; Ishihara S; Adachi K; Kinoshita Y
    Digestion; 2008; 77(3-4):166-72. PubMed ID: 18577886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in mice.
    Suchitra AD; Dkhar SA; Shewade DG; Shashindran CH
    World J Gastroenterol; 2003 Apr; 9(4):779-83. PubMed ID: 12679931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved use of the [13C]octanoic acid breath test as intra-individual parameter to study the effect of a prokinetic drug on gastric emptying in preterm infants with oral feeding intolerance.
    Kulik W; van Weissenbruch MM; Menelik N; Cranendonk A; Kneepkens CM; Lafeber HN
    J Chromatogr B Biomed Sci Appl; 2001 Jan; 750(1):147-53. PubMed ID: 11204215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of AS-4370 on gastric emptying--double-blind clinical pharmacological study].
    Kanaizumi T; Nakano H; Matsui T; Ishikawa H; Shimizu R; Paku S; Kuriya N
    Nihon Heikatsukin Gakkai Zasshi; 1990 Jun; 26(3):161-74. PubMed ID: 2087015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of mosapride on motility of the small intestine and caecum in normal horses after jejunocaecostomy.
    Okamura K; Sasaki N; Kikuchi T; Murata A; Lee I; Yamada H; Inokuma H
    J Vet Sci; 2009 Jun; 10(2):157-60. PubMed ID: 19461212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy.
    Asakawa H; Hayashi I; Fukui T; Tokunaga K
    Diabetes Res Clin Pract; 2003 Sep; 61(3):175-82. PubMed ID: 12965107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation into the effects of mosapride on motility of Guinea pig stomach, ileum, and colon.
    Ji SW; Park HJ; Cho JS; Lim JH; Lee SI
    Yonsei Med J; 2003 Aug; 44(4):653-64. PubMed ID: 12950122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 5-HT4 receptor agonist mosapride attenuates inflammation of reflux esophagitis.
    Zhuang ZH; Zou FM; Tang DP; Zhuang JY; Wei JJ; Yang LY
    Hepatogastroenterology; 2014; 61(129):115-9. PubMed ID: 24895805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of DA-9701, a novel prokinetic agent, on stress-induced delayed gastric emptying and hormonal changes in rats.
    Jung YS; Kim MY; Lee HS; Park SL; Lee KJ
    Neurogastroenterol Motil; 2013 Mar; 25(3):254-9, e166. PubMed ID: 23216854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of mosapride citrate on human plasma levels of motilin, gastrin, somatostatin, and secretin.
    Itoh H; Nagano T; Takeyama M
    Biol Pharm Bull; 2001 Sep; 24(9):1072-5. PubMed ID: 11558572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prokinetic drugs for gastric emptying in critically ill ventilated patients: Analysis through breath testing.
    Hersch M; Krasilnikov V; Helviz Y; Zevin S; Reissman P; Einav S
    J Crit Care; 2015 Jun; 30(3):655.e7-13. PubMed ID: 25746849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome.
    Kanazawa M; Watanabe S; Tana C; Komuro H; Aoki M; Fukudo S
    Neurogastroenterol Motil; 2011 Aug; 23(8):754-e332. PubMed ID: 21615623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of mosapride on ruminal motility in cattle.
    Arai S; Haritani M; Sawada H; Kimura K
    J Vet Med Sci; 2019 Jul; 81(7):1017-1020. PubMed ID: 31155551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prokinetic effects of a new 5-HT
    Yin J; Xu X; Song G; Han HS; Kim HW; Chen JD
    J Gastroenterol Hepatol; 2017 Mar; 32(3):625-630. PubMed ID: 27418395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of AS-4370 on gastric motility in patients with diabetic autonomic neuropathy].
    Yamada M; Hongo M; Okuno Y; Nishimura N; Ueno M; Kawakami H; Toyota T
    J Smooth Muscle Res; 1992 Aug; 28(4):153-8. PubMed ID: 1297469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of Flos Lonicerae Japonicae extract on gastro-intestinal motility function.
    Nam Y; Lee JM; Wang Y; Ha HS; Sohn UD
    J Ethnopharmacol; 2016 Feb; 179():280-90. PubMed ID: 26743226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral hypertonic electrolyte-glucose/mosapride complex solution for resuscitation of burn shock in dogs.
    Hu Q; Chai J; Hu S; Zhou G; Sheng Z
    J Burn Care Res; 2012; 33(2):e63-9. PubMed ID: 22138812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 5-HT4 receptor agonist mosapride attenuates NSAID-induced gastric mucosal damage.
    Fujisawa M; Murata T; Hori M; Ozaki H
    J Gastroenterol; 2010 Feb; 45(2):179-86. PubMed ID: 20012106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 5-HT4 agonist, mosapride, enhances intrinsic rectorectal and rectoanal reflexes after removal of extrinsic nerves in guinea pigs.
    Kojima Y; Nakagawa T; Katsui R; Fujii H; Nakajima Y; Takaki M
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G351-60. PubMed ID: 15817810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.